Test the efficacy of vitamin D to improve non-alcoholic steatohepatitis with regard to biochemical and histological parameters. * Trial with medicinal product
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
22
Vitamin D3, 2.100 IU/d p.o.
Placebo Tbl. p.o.
University Hospital Zurich, Gastroenterology and Hepatology
Zurich, Canton of Zurich, Switzerland
Kantonsspital St. Gallen
Sankt Gallen, Switzerland
Change from Baseline in serum alanine aminotransferase levels at week 48
Time frame: Measurement at week 0 and week 48
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.